GCPGC in Chemotherapy-induced Neutropenia

This study is adaptive design and it consists of stage I and stage II. Stage I is multi-center, parallel-group, single-blind, phase II study to determine the adequate dose of GCPGC and stage II is multi-center, parallel-group, open label,phase III study to evaluate the efficacy and safety of once per cycle GCPGC in chemotherapy-induced neutropenia compared to daily filgrastim